Coronary stents and noncardiac surgery: Current clinical challenges and conundrums

Preventive Cardiology

Volumn 13, Issue 1, 2010, Pages 8-13

  Heir, Jagtar S ^a   Gottumukkala, Vijaya ^a   Singh, Manmeet ^a   Yusuf, Syed Wamique ^a   Riedel, Bernhard ^b,c  

^a Department of Anesthesiology and Perioperative Medicine ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN; PACLITAXEL; SIMVASTATIN; STATIN; TROPONIN;

AGED; ANGIOPLASTY; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; DYSPNEA; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; NOTE; OXYGEN THERAPY; PRIORITY JOURNAL; PROSTATECTOMY; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; STENT THROMBOSIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; MALE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 72549105878     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2009.00044.x     Document Type: Note

References (33)

1. Arjomand H, Turi Z, McCormick D. Percutaneous coronary intervention: historical perspectives, current status, and future direction. Am Heart J 2003, 146:787-796.
2. Biondi-Zoccai GC, Agostoni P, Abbate A. Adjusted indirect comparison of intracoronary drug eluting stent: evidence from a metaanalysis of randomized bare metal stent controlled trials. Int J Cardiol 2005, 100:119-123.
3. Iakovou I, Schmidt T, Bonizzoni E. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005, 293:2126-2130.
4. Grines CL, Bonow RO, Casey DE. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007, 115(6):813-818.
5. Jaffe R, Strauss BH. Late and very late thrombosis of drug eluting stents. Evolving concepts and perspectives. J Am Coll Cardiol 2007, 50(2):119-127.
6. Nguyen TA, Diodati JG, Pharand C. Resistance to Clopidrogel: a review of the evidence. J Am Coll Cardiol 2005, 45(8):1157-1164.
7. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: part I. Evolution of percutaneous coronary intervention. Anesth Analg 2008, 107(2):552-569.
8. Burger W, Chemnitius JM, Kneissl GD. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: a review and meta-analysis. J Intern Med 2005, 257(5):399-414.
9. Spahn DR, Howell SJ, Delabays A. Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 2006, 96(5):675-677.
10. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002, 324(7239):71-86.
11. Chu MW, Wilson SR, Novick RJ. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004, 78(5):1536-1541.
12. Chen L, Bracey AW, Radovancevic R. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004, 128(3):425-431.
13. Shim JK, Choi YS, Oh YJ. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007, 134(1):59-64.
14. Kennedy MT, Roche S, Fleming SM. The association between aspirin and blood loss in hip fracture patients. Acta Orthop Belg 2006, 72(1):29-33.
15. Steinhubl SR, Berger PB, Mann JT. Early and sustained dual antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002, 288(18):2411-2420.
16. Yan BP, Gurvitch R, Ajani AE. Double jeopardy: balance between stent thrombosis with prolonged dual antiplatelet therapy after drug eluting stent implantation. Cardiovasc Revasc Med 2006, 7(3):155-158.
17. Cutlip DE, Baim DS, Ho KK. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001, 103(15):1967-1971.
18. Leon MB, Baim DS, Popma JJ. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998, 339:1665-1671.
19. Newsome LT, Kutcher MA, Ghandi SK. A Protocol for the Perioperative Management of Patients with Intracoronary Drug-eluting Stents APSF Newsletter, Winter 2006-07 Wake Forest Model
20. Bertrand ME, Legrand V, Boland J. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlodipine (fantastic) study. Circulation 1998, 98(16):1597-1603.
21. Ferrari E, Benhamou M, Cerboni P. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005, 45(3):456-459.
22. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007, 49(22):2145-2150.
23. Lip YHG, Chin SPB, Blann DA. Cancer and the prothrombotic state. Lancet Oncol 2002, 3(1):27-34.
24. Hara Y, Steiner M, Baldini MG. Characterization of the platelet aggregating activity of tumor cells. Cancer Res 1980, 40:1217-1222.
25. Pober JS. Warner-Lambert/Parke-Davis award lecture. Cytokine mediated activation of vascular endothelium. Am J Pathol 1988, 133(3):426-433.
26. Gertz K, Laufs U, Lindauer U. Withdrawal of statin abrogates stroke protection in mice. Stroke 2003, 34(2):551-557.
27. Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 2002, 91(2):173-179.
28. Bavry AA, Kumbhani DJ, Helton TJ. Late thrombosis of drug eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006, 119(12):1056-1061.
29. Moreno R, Fernandez C, Hernandez R. Drug eluting stent thrombosis results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005, 45(6):954-959.
30. Bavry AA, Kumbhani DJ, Helton TJ. What is the risk of stent thrombosis associated with the use of Paclitaxel eluting stents for percutaneous coronary intervention? A meta analysis. J Am Coll Cardiol 2005, 45(6):941-946.
31. Stone G. Meta analysis and registries, insights and unsettled issues. Presented at American College of Cardiology Meeting; March 11-14, 2006; Atlanta GA
32. Erbel R, Di Mario C, Bartunek J. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomized multicentre trial. Lancet 2007, 369(9576):1869-1875.
33. Brilakis ES, Orford JL, Gasseas P. Outcome of patients undergoing balloon angioplasty. Am J Cardiol 2005, 96(4):512-514.